EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beta-Blocker Medication: Between Cardiovascular Benefits and Functional Limitations in Medical Rehabilitation

Lavinia Bodeanu, Liliana-Elena Stanciu, Andreea-Dalila Nedelcu, Andreea-Bianca Uzun, Mădălina-Gabriela Iliescu

ARS Medica Tomitana · 01.11.2025 · 31 (4) · 135-140

DOI: 10.2478/arsm-2025-0018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ARS Medica Tomitana, online erschienen am 13.06.2026. Verfasst von Lavinia Bodeanu und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

With multiple indications in both cardiovascular and non-cardiovascular diseases, beta-blockers exert complex effects on the cardiovascular system and energy metabolism, potentially impacting functional performance in medical rehabilitation programs. While their efficacy in controlling cardiac function is well-documented, the literature reports inconsistent results regarding the effects of this drug class on metabolic parameters and exercise tolerance. In the context of medical rehabilitation, these aspects justify the evaluation of the potential impact of beta-blockers on functional response. Materials and Methods: The study had a prospective design and included 320 patients hospitalized between January and December 2025 at the Techirghiol Balneary and Rehabilitation Sanatorium. The antihypertensive medication used was analyzed, with patients grouped based on the administration of beta-blockers or other classes of antihypertensive drugs. Clinical observations regarding exercise tolerance were noted according to the timing of beta-blocker medication administration. Body Mass Index (BMI) was calculated to compare the weight status between groups. Functional evaluation was performed at the beginning and at the end of the rehabilitation program using the Visual Analog Scale (VAS) and the Six-Minute Walk Test (6MWT).

Results

Of the included patients, 179 were under treatment with beta-blockers, with metoprolol being the predominantly used active substance. In this group, 72% had BMI values above 25 kg/m², with a gender distribution of 59.7% females and 40.3% males. Comparative analysis revealed higher average BMI values in women treated with beta-blockers compared to those receiving other classes of antihypertensive drugs. Dynamic evaluation indicated a more limited functional improvement in the group of patients treated with beta-blockers.

Conclusion

Differences were observed between patients treated with beta-blockers and those treated with other classes of antihypertensive drugs regarding metabolic and functional parameters. These findings highlight the importance of considering antihypertensive therapy and monitoring exercise tolerance in the context of medical rehabilitation programs.

Zitieren

APA

Bodeanu, L., Stanciu, L., Nedelcu, A., Uzun, A., & Iliescu, M. (2025). Beta-Blocker Medication: Between Cardiovascular Benefits and Functional Limitations in Medical Rehabilitation. ARS Medica Tomitana, 31(4), 135-140. https://doi.org/10.2478/arsm-2025-0018

Vancouver

Bodeanu L, Stanciu L, Nedelcu A, Uzun A, Iliescu M. Beta-Blocker Medication: Between Cardiovascular Benefits and Functional Limitations in Medical Rehabilitation. ARS Medica Tomitana. 2025;31(4):135-140. doi:10.2478/arsm-2025-0018

BibTeX
@article{Bodeanu2025,
  author = {Bodeanu, Lavinia and Stanciu, Liliana-Elena and Nedelcu, Andreea-Dalila and Uzun, Andreea-Bianca and Iliescu, Mădălina-Gabriela},
  title = {Beta-Blocker Medication: Between Cardiovascular Benefits and Functional Limitations in Medical Rehabilitation},
  journal = {ARS Medica Tomitana},
  year = {2025},
  volume = {31},
  number = {4},
  pages = {135--140},
  doi = {10.2478/arsm-2025-0018}
}
Kostenlos starten →